Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trelagliptin Succinate Monotherapy in Chinese Patients With Type 2 Diabetes Mellitus
CTR20180575Phase 3Completed
- Sponsor
- Kelun-Biotech
- Start
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of trelagliptin in type 2 diabetes mellitus (T2DM), sponsored by Kelun-Biotech. Started May 2018; status: completed.
02
Drugs
trelagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on CTR20180575.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20180575.